期刊文献+

胰岛素抵抗肥胖大鼠体内增食欲素A与丝氨酸蛋白酶抑制剂及脂代谢的相关性研究 被引量:4

Correlation between Orexin A and Vaspin in Lipid Metabolism in Obese Rats with Insulin Resistance
下载PDF
导出
摘要 目的分析胰岛素抵抗(IR)肥胖大鼠体内增食欲素A(orexinA)与脂肪组织特异性丝氨酸蛋白酶抑制剂(vaspin)的相关性,阐明IR病理过程中orexin参与脂肪代谢的可能作用机制。方法4周龄sD雄性大鼠75只,随机分为正常饮食(NC)组(n=20)和高脂肪膳食(HF)组(n=55),建立IR肥胖大鼠模型,钳夹技术评定IR及脂代谢相关指标。大鼠皮下注射orexinA(1×10^-8,1×10^-6mol/L),用酶联免疫吸附法检测血清orexinA和vaspin。结果(1)喂养6周后,与NC组比较,HF组大鼠血糖、胰岛素、TC、TG、LDL-C均增高(P均〈0.05);与NC组比较,GIR60~120降低[(16.31±1.54)VS(30.22±2.76)mg/(kg·min),P〈0.05];(2)HF组较NC组血清vaspin水平增加177.08%(P〈0.05);皮下注射orexinA(1×10^-8,1×l0^-7,1×10^-6mol/L),NC组大鼠血清vaspin分别增加25.00%、68.75%、120,83%,HF组大鼠血清vaspin分别增加7.52%、24.06%、40.60%;(3)IR肥胖大鼠vaspin与orexinA、血糖、胰岛素、TC、TG、LDL—C呈正相关(r分别为0.482、0.515、0.303、0.388、0.255、0.253,P=0.04),与HDL—C呈负相关(r=-0.226,P均〈0.05)。结论高脂膳食诱导的IR肥胖大鼠机体内orexinA与vaspin密切相关,orexinA增强vaspin的表达,进而参与肥胖大鼠机体内IR的发生。 Objective To investigate the correlation between orexin A and the serine proteinase inhibitor vaspin in obese rats with insulin resis- tance (IR) induced by high-fat diet and elaborate the possible action mechanism of orexin involvement in fat metabohsm in IR pathological process. Methods A total of 75 4-week-old male Sprague-Dawley rats were randomly divided into the normal dietary group (NC group, n =20) and the high -fat dietary group ( HF group, n =55 ) to establish the model of obese rats with IR, the euglycemic insulin clamp technique was used to determine re- lated indicators of insulin resistance and lipid metabolism. The rats were treated with orexin A ( 1 × 10^-8 - 1 × 10^-6mol/L) by hypodermic injection. The serum levels of orexin A and vaspin in rats were detected with enzyme linked immunosorbent assay. Results After 6 weeks of high-fat diet, the se- rum glucose, insulin, TC, TG and LDL-C were increased significantly in HF group than in NC group, while GIR60-120 in obese rats was decreased significantly [ (16.31±1.54) vs (30.22±2.76)mg/(kg. min), P 〈 0.05 ]. The serum vaspin level was increased 177.08% in HF group compared with NC group (P 〈 0.05 ). With hypodermic injection of orexin A ( 1 × 10^-8 mol/L, 1 × 10^-7 mol/L and 1 × 10^-6 mol/L), the levels of serum vaspin in- creased 25.00%, 68.75%, and 120.83% in NC group and increased 7.52%, 24.06%, and 40.60% in HF group. There was a positive correlation between vaspin and orexin A, glucose, insulin, TC, TG, and LDL-C (r1=0A82, P1 = 0.02, r2=0.515, P2 = 0.02, r3 =0.303, P3 = 0.04, r4=0.388,r4 = 0.03, r5=0.255, P5 = 0.04, r6=0.253, P6 = 0.04) and a negative correlation between vaspin and HDL-C (r =-0.226, P = 0.04) in obese rats with IR. Conclusion High-fat diet can induce insulin resistance and obesity in rats, and orexin A is closely correlated to vaspin in obese rats with insu- lin resistance. Orexin A increases serum vaspin expression and thus involves in onset of insulin resistance in obese ra
出处 《中国医科大学学报》 CAS CSCD 北大核心 2015年第2期105-108,共4页 Journal of China Medical University
基金 国家自然科学基金(81470998 81071460 81271996)
关键词 增食欲素A VASPIN 胰岛素抵抗 肥胖 orexin A vaspin insulin resistance obesity
  • 相关文献

参考文献3

二级参考文献27

  • 1Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Mefformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008; 57: 1501-1507. 被引量:1
  • 2Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009; 160: 65-70. 被引量:1
  • 3Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377. 被引量:1
  • 4Kloting N, Berndt J, Kralisch S, Kovacs E Fasshauer M, Schon MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339: 430-436. 被引量:1
  • 5Gonzalez-Ortiz M, Martinez-Abundis E. Comparison of several formulas to assess insulin action in the fasting state with the hyperglycemic-hyperinsulinemic clamp technique in healthy individuals. Rev Invest Clin 2003; 55:419-422. 被引量:1
  • 6Bao Y, Lu J, Wang C, Yang M, Li H, Zhang X, et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008; 201: 378-384. 被引量:1
  • 7World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complication. WHO/NCD/NCS 1999: 31-33. (Accessed at http://whqlibdoc. who. int/hq/1999/WHO_NCD_NCS_99. 2.pdj-'). 被引量:1
  • 8WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163. 被引量:1
  • 9Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008; 93: 247-251. 被引量:1
  • 10Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007; 18: 240-245. 被引量:1

共引文献88

同被引文献32

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部